Intestinal homeostasis

Intestinal homeostasis is a complex physiological state of equilibrium within the gastrointestinal tract, maintained by the dynamic interplay between the host immune system, the intestinal epithelial barrier, and the commensal microbiota (Okumura & Takeda, 2017, Nature Reviews Immunology [https://www.nature.com/articles/nri.2017.111]). This regulatory network ensures efficient nutrient absorption and immune tolerance toward beneficial bacteria while maintaining a robust defense against enteric pathogens. A breakdown in these homeostatic mechanisms, often referred to as dysbiosis or barrier dysfunction, is central to the pathogenesis of chronic inflammatory conditions such as Crohn's disease and ulcerative colitis (NIH, 2023, National Institute of Diabetes and Digestive and Kidney Diseases [https://www.niddk.nih.gov/health-information/digestive-diseases/inflammatory-bowel-disease]). While not a single molecular target itself, 'intestinal homeostasis' is the primary therapeutic objective for many gastrointestinal drugs that target specific inflammatory mediators like TNF-alpha or integrins (StatPearls, 2023, Infliximab [https://www.ncbi.nlm.nih.gov/books/NBK470312/]). Achieving this state involves the coordination of various signaling pathways, and its maintenance is often monitored using clinical biomarkers like fecal calprotectin (Mayo Clinic, 2023 [https://www.mayocliniclabs.com/test-catalog/overview/64400]). Consequently, the term describes a broad biological process rather than a specific receptor or enzyme.

Other names

Gut homeostasisGastrointestinal homeostasisIntestinal balanceMucosal homeostasis

Modulation of mucosal immunity, restoration of epithelial barrier integrity, and reduction of pro-inflammatory cytokine signaling to restore physiological equilibrium.